JMP Securities Reiterates Market Perform Rating for Apyx Medical (NASDAQ:APYX)

Apyx Medical (NASDAQ:APYX)‘s stock had its “market perform” rating reaffirmed by JMP Securities in a report issued on Monday, Benzinga reports.

Apyx Medical Price Performance

Apyx Medical stock opened at $1.08 on Monday. The company has a fifty day simple moving average of $1.27 and a 200-day simple moving average of $1.43. Apyx Medical has a 12-month low of $0.97 and a 12-month high of $4.00. The company has a current ratio of 5.33, a quick ratio of 4.45 and a debt-to-equity ratio of 2.26. The stock has a market cap of $37.42 million, a P/E ratio of -1.64 and a beta of 1.20.

Apyx Medical (NASDAQ:APYX) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.01). The company had revenue of $12.15 million for the quarter, compared to analyst estimates of $12.67 million. Apyx Medical had a negative return on equity of 105.45% and a negative net margin of 57.86%. During the same quarter in the prior year, the business earned ($0.11) earnings per share. Equities analysts expect that Apyx Medical will post -0.69 EPS for the current fiscal year.

Institutional Trading of Apyx Medical

Institutional investors have recently added to or reduced their stakes in the stock. Kingsview Wealth Management LLC purchased a new stake in Apyx Medical during the fourth quarter worth about $32,000. ProVise Management Group LLC purchased a new stake in Apyx Medical during the fourth quarter worth about $35,000. RPg Family Wealth Advisory LLC purchased a new stake in Apyx Medical during the second quarter worth about $101,000. Perkins Capital Management Inc. boosted its holdings in Apyx Medical by 7.0% during the first quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after buying an additional 15,000 shares in the last quarter. Finally, Rathbones Group PLC boosted its holdings in Apyx Medical by 148.0% during the second quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after buying an additional 150,000 shares in the last quarter. Hedge funds and other institutional investors own 55.33% of the company’s stock.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.